Forte Biosciences Inc.

NASDAQ: FBRX · Real-Time Price · USD
11.85
1.03 (9.52%)
At close: Aug 15, 2025, 3:59 PM
11.61
-2.03%
After-hours: Aug 15, 2025, 04:53 PM EDT

Forte Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-35.48M -31.48M -13.88M -21.71M
Depreciation & Amortization
39K 9K n/a 36K
Stock-Based Compensation
3.1M 3.28M 4.01M 4.21M
Other Working Capital
-1.26M -663K 1.47M 1.01M
Other Non-Cash Items
-158K -131K 3.81M 61K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.76M -392K 1.68M 720K
Operating Cash Flow
-30.75M -28.71M -8.19M -16.68M
Capital Expenditures
-37K -88K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-35.96M -9.96M n/a n/a
Sales Maturities Of Investments
n/a 10.1M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-35.99M 47K n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-1K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.14M -44K 12K -44K
Financial Cash Flow
51.86M 24.68M 7.24M -44K
Net Cash Flow
-14.88M -3.98M -944K -16.72M
Free Cash Flow
-30.78M -28.79M -8.19M -16.68M